Clinical Trial: A Study of SHR-A1811 in Subjects With Ovarian Cancer

U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06828354) titled 'A Study of SHR-A1811 in Subjects With Ovarian Cancer' on Feb. 10.

Brief Summary: This is an open-label study to evaluate the safety and efficacy of SHR-A1811 for injection in subjects with ovarian cancer.

Study Start Date: Feb., 2025

Study Type: INTERVENTIONAL

Condition: Ovarian Cancer

Intervention: DRUG: SHR-A1811

SHR-A1811.

DRUG: Paclitaxel Injection

Paclitaxel Injection.

DRUG: Doxorubicin Hydrochloride Liposome Injection

Doxorubicin Hydrochloride Liposome Injection.

DRUG: Gemcitabine Hydrochloride for Injection

Gemcitabine Hydrochloride for Injection.

DRUG: Topotecan Hydrochloride for Injection

Topotecan Hydrochlor...